Singapore Clinical Trial: DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLOZASIRAN IN ADULTS WITH SEVERE HYPERTRIGLYCERIDEMIA AT HIGH RISK OF ACUTE PANCREATITIS (SHASTA-5 STUDY)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLOZASIRAN ... Read More

Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) versus Treatment of Investigator’s Choice (IC) in Patients with Endometrial Cancer After Platinum-Based Chemotherapy and PD(L)-1 Therapy

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) versus Treatment of Invest... Read More

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy Versus Physician’s Choice of Chemotherapy in Participants With B7-H4-selected Advanced/Metastatic Endometrial Cancer Who Progressed on or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More

Clinical Trial: Clinical Trial Protocol for the Effectiveness and Safety of Radiofrequency Skin Therapy Equipment in Improving Facial Skin Wrinkles

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894120) titled 'Clinical Trial Protocol for the Effectiveness and Safety of Radiofrequency Skin Therapy Equ... Read More

Singapore Clinical Trial: A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combination with Pembrolizumab for First-Line Treatment of PD-L1-positive, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in... Read More

Clinical Trial: Toxicity of Intensive First-Line Treatment for Adult Burkitt Lymphoma: A Retrospective Observational Study

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895927) titled 'Toxicity of Intensive First-Line Treatment for Adult Burkitt Lymphoma: A Retrospective Obse... Read More

Clinical Trial: MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894458) titled 'MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer' on... Read More

Clinical Trial: Intravenous Lidocaine Versus Erector Spinae Plane Block After Lumbar Arthrodesis (LIBERA)

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895368) titled 'Intravenous Lidocaine Versus Erector Spinae Plane Block After Lumbar Arthrodesis (LIBERA)' ... Read More

Clinical Trial: Virtual Reality to Advance Dementia Care and Quality of Life

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07893678) titled 'Virtual Reality to Advance Dementia Care and Quality of Life' on Oct. 19. Brief Summary: T... Read More

Clinical Trial: Prospective Observational Cohort Study for Predicting Unruptured Intracranial Aneurysm Rupture Risk Using Blood Pressure Variability and 3D Structural Evolution

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07893574) titled 'Prospective Observational Cohort Study for Predicting Unruptured Intracranial Aneurysm Rupt... Read More

• ««
• «
• 933
• 934
• 935
• 936
• 937
• 938
• 939
• 940
• 941
• 942
• »
• »»